Our
European Drug Safety Summit 2018 will be taking place on the 7th & 8th March 2018, London, UK. The two day event will bring together pharmacovigilance personnel from key pharmaceutical companies and will address the challenges in monitoring and maintaining
drug safety strategies, will discuss how to apply new technologies and strategic approaches to effectively manage drug safety and will discover key developments in the handling, analysis and reporting of adverse events during trials and understand the regulators requirements with the aim of speeding drugs to market whilst mitigating the risk of recall.
Key Topics
- Meeting Safety Requirement: Regulator's Perspective
- Building a Pharmacovigilance Strategy
- Evolving PV Strategies for Tomorrow
- Technological Advancement in Pharmacovigilance
- Clinical Data Management
- The Role of Big Data and Social Media in PV
- Ensure Drug Safety & Risk Minimisation Measures
- Latest Development & Innovation Approach for Effective Signal Management
- Development of Qualified Personal Responsible for Pharmacovigilance (QPPV)
- Pharmacovigilance for Advanced Therapies
In the Chair:
- Monica F. Buchberger (Rusu), Director PV Governance & QPPV, Global Pharmacovigilance Innovation & Development Established Pharmaceuticals, Abbott Laboratories GmbH
Confirmed Speakers:
- Mircea Ciuca, Global Head Medical & Clinical Drug Safety, Vifor Pharma
- Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV, ADIENNE Pharma & Biotech
- David J Lewis, Senior Adviser Pharmacovigilance, Novartis
- Monika Manske, Associate Director of Global Pharmacovigilance Governance, Mylan Pharmaceuticals ltd
- Elizabeth Ursell, Director Pharmocoviglilance, Mapi Group
- Ricarda Tiemeyer, Head of Drug Safety & PoC Medical Information, Roche Pharma (Schweiz) AG
- Vicky Edwards, QPPV Head of Affilate Vigilance, AbbVie
- Lisa Stagi, Drug Safety & Quality Head, Roche S.p.A. Italy
- Dominic Bowers, Head of Clinical Operations , Cell and Gene Therapy Catapult.
- Saad Shakir, Director, Drug Safety Research Unit
- Uwe Gudat, Safety Head, Fresenius Kabi
- Lucy Hampshire, Director, Medicines Quality Organisation – Europe,
- Eli Lilly and Company Limited
- Katrien Solemé, Pharmacovigilance Strategy Lead, Global Quality, Bristol Myers Squibb
- Manni Kuthiala, PV Affiliate – Strategic Alliance Manager, Roche
- Alison Monckton, Principal Clinical Data Manager, Allergy Therapeutics
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side of the page.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Who will attend?
Attendees will be drawn primarily from pharmaceutical, biotechnology and contract research organisations and include VPs, Directors and Managers/Scientists working in Drug Safety, Pharmacovigilance, Epidemiology, Clinical Research and Development, Clinical Trial Management, Pharmacology, Regulatory Affairs and Compliance, Strategy and Business Development, Risk Management, QPPV
Venue
Venue to be confirmedLondon, United Kingdom
